Form 8-K - Current report:
SEC Accession No. 0001104659-24-071337
Filing Date
2024-06-13
Accepted
2024-06-13 17:06:11
Documents
13
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417255d1_8k.htm   iXBRL 8-K 34252
  Complete submission text file 0001104659-24-071337.txt   211652

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20240613.xsd EX-101.SCH 3054
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20240613_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20240613_pre.xml EX-101.PRE 22385
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2417255d1_8k_htm.xml XML 3795
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40363 | Film No.: 241042073
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)